Salome Charalambous

Summary

Affiliation: Aurum Institute for Health Research
Country: South Africa

Publications

  1. ncbi request reprint Contribution of reinfection to recurrent tuberculosis in South African gold miners
    S Charalambous
    Aurum Institute for Health Research, Johannesburg, South Africa
    Int J Tuberc Lung Dis 12:942-8. 2008
  2. ncbi request reprint Evaluation of a workplace HIV treatment programme in South Africa
    Salome Charalambous
    Aurum Institute for Health Research, Johannesburg, South Africa
    AIDS 21:S73-8. 2007
  3. pmc Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme
    Salome Charalambous
    The Aurum Institute, Johannesburg, South Africa
    AIDS 24:S5-13. 2010
  4. ncbi request reprint Establishing a workplace antiretroviral therapy programme in South Africa
    S Charalambous
    Aurum Institute for Health Research, Marshalltown, South Africa
    AIDS Care 19:34-41. 2007
  5. pmc Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program
    Christopher J Hoffmann
    Aurum Institute for Health Research and 2Toga Laboratories, Johannesburg, South Africa
    Clin Infect Dis 47:1479-85. 2008
  6. pmc Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events
    Christopher J Hoffmann
    Aurum Institute for Health Research, Johannesburg, South Africa
    AIDS 22:67-74. 2008
  7. pmc HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South Africa
    Christopher J Hoffmann
    Aurum Institute for Health Research, Johannesburg, South Africa
    AIDS 23:1784-6. 2009
  8. ncbi request reprint Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B
    Christopher J Hoffmann
    Aurum Institute for Health Research, Johannesburg, South Africa
    AIDS 21:1301-8. 2007
  9. pmc Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa
    Christopher J Hoffmann
    Aurum Institute, Johannesburg, South Africa
    AIDS 24:1709-16. 2010
  10. pmc Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study
    Kavindhran Velen
    The Aurum Institute, Johannesburg, South Africa
    PLoS ONE 8:e64459. 2013

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Contribution of reinfection to recurrent tuberculosis in South African gold miners
    S Charalambous
    Aurum Institute for Health Research, Johannesburg, South Africa
    Int J Tuberc Lung Dis 12:942-8. 2008
    ..A gold mine in South Africa...
  2. ncbi request reprint Evaluation of a workplace HIV treatment programme in South Africa
    Salome Charalambous
    Aurum Institute for Health Research, Johannesburg, South Africa
    AIDS 21:S73-8. 2007
    ..To review the experience of implementing a workplace HIV care programme in South Africa and describe treatment outcomes in sequential cohorts of individuals starting antiretroviral therapy (ART)...
  3. pmc Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme
    Salome Charalambous
    The Aurum Institute, Johannesburg, South Africa
    AIDS 24:S5-13. 2010
    ..To describe the association between isoniazid preventive therapy (IPT) and mortality among individuals starting antiretroviral therapy (ART) in a workplace programme in South Africa where tuberculosis (TB) incidence is very high...
  4. ncbi request reprint Establishing a workplace antiretroviral therapy programme in South Africa
    S Charalambous
    Aurum Institute for Health Research, Marshalltown, South Africa
    AIDS Care 19:34-41. 2007
    ..The model may be generalizable to other employment health services in settings of high HIV prevalence, and as a model for implementing ART in other types of health-care settings...
  5. pmc Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program
    Christopher J Hoffmann
    Aurum Institute for Health Research and 2Toga Laboratories, Johannesburg, South Africa
    Clin Infect Dis 47:1479-85. 2008
    ..We evaluated the impact of chronic hepatitis B on HIV virologic response, changes in CD4 cell count, hepatotoxicity, and mortality among Africans receiving highly active antiretroviral therapy (HAART)...
  6. pmc Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events
    Christopher J Hoffmann
    Aurum Institute for Health Research, Johannesburg, South Africa
    AIDS 22:67-74. 2008
    ..To describe the safety and tolerability of zidovudine, lamivudine, and efavirenz in a low-income setting...
  7. pmc HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South Africa
    Christopher J Hoffmann
    Aurum Institute for Health Research, Johannesburg, South Africa
    AIDS 23:1784-6. 2009
    ..6). In regression modeling, including baseline HIV RNA and nonnucleoside reverse transcriptase inhibitor agent, stavudine dose remained unassociated with suppression...
  8. ncbi request reprint Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B
    Christopher J Hoffmann
    Aurum Institute for Health Research, Johannesburg, South Africa
    AIDS 21:1301-8. 2007
    ..Hepatotoxicity is a significant complication of antiretroviral therapy (ART). We assessed the incidence of and risk factors for hepatotoxicity among HIV-infected individuals on ART in South Africa...
  9. pmc Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa
    Christopher J Hoffmann
    Aurum Institute, Johannesburg, South Africa
    AIDS 24:1709-16. 2010
    ..To assess the effectiveness of cotrimoxazole preventive therapy (CPT) among individuals with CD4 cell count above 200 cells/microl and varying WHO clinical stages in reducing mortality during combination antiretroviral therapy (cART)...
  10. pmc Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study
    Kavindhran Velen
    The Aurum Institute, Johannesburg, South Africa
    PLoS ONE 8:e64459. 2013
    ....
  11. pmc A novel HIV treatment model using private practitioners in South Africa
    Craig Innes
    The Aurum Institute, Johannesburg, South Africa
    Sex Transm Infect 88:136-40. 2012
    ..The extent of the HIV epidemic in South Africa may render the public sector capacity inadequate to manage all patients requiring antiretroviral treatment (ART). Private practitioners are an underutilised resource...
  12. doi request reprint Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control
    Tendesayi Kufa
    Aurum Institute for Health Research, Johannesburg, South Africa
    J Acquir Immune Defic Syndr 60:e22-8. 2012
    ..We describe factors associated with undiagnosed TB among HIV-infected patients attending an HIV clinic in South Africa and discuss implications for the 3 Is...
  13. pmc HIV infection does not affect active case finding of tuberculosis in South African gold miners
    James J Lewis
    Aurum Institute for Health Research, Postnet Suite 300, Private Bag X 30500, Houghton, Johannesburg, South Africa 2041
    Am J Respir Crit Care Med 180:1271-8. 2009
    ..Gold miners in South Africa undergo annual radiological screening for tuberculosis in an occupational health center of a gold mining company, but the optimal screening algorithm is unclear...
  14. doi request reprint High tuberculosis prevalence in a South african prison: the need for routine tuberculosis screening
    Lilanganee Telisinghe
    Aurum Institute, Johannesburg, South Africa CAPRISA, University of KwaZulu Natal, Durban, South Africa
    PLoS ONE 9:e87262. 2014
    ..In addition we investigated risk factors for undiagnosed tuberculosis, to explore if screening strategies could be targeted to high risk groups, and, the performance of screening tools for tuberculosis...
  15. pmc A study of patient attitudes towards decentralisation of HIV care in an urban clinic in South Africa
    Rachel Mukora
    Aurum Institute, Johannesburg, South Africa
    BMC Health Serv Res 11:205. 2011
    ..This cross-sectional qualitative study investigates attitudes towards down-referral of ART delivery care among patients currently receiving care in a centralized tertiary HIV clinic...
  16. pmc Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study
    Katherine L Fielding
    London School of Hygiene and Tropical Medicine, London, UK
    BMC Infect Dis 8:93. 2008
    ..Reasons for the variation in reported treatment outcomes from antiretroviral therapy (ART) programmes in developing countries are not clearly defined...
  17. pmc "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme
    Mison Dahab
    Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    BMC Public Health 8:63. 2008
    ..This qualitative study examines potential barriers to, and facilitators of, adherence to ART in a workplace programme in South Africa...
  18. pmc Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa
    Liesl S Page-Shipp
    Aragon Consulting, Craighall, South Africa
    Sex Transm Infect 83:383-6. 2007
    ..To investigate attitudes to directly observed antiretroviral therapy (DOT ART) among HIV infected adults attending a workplace HIV care programme in South Africa...
  19. ncbi request reprint Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?
    Gavin J Churchyard
    Aurum Health Research, Welkom, South Africa
    AIDS 17:2063-70. 2003
    ..To determine the efficacy of secondary preventive therapy against tuberculosis (TB) among gold miners working in South Africa...
  20. ncbi request reprint Stable incidence rates of tuberculosis (TB) among human immunodeficiency virus (HIV)-negative South African gold miners during a decade of epidemic HIV-associated TB
    Elizabeth L Corbett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
    J Infect Dis 188:1156-63. 2003
    ..94, for 1995-1997, 0.96, for 1998-1999, and 1.05, for 1999-2000. Preventing a secondary epidemic of TB among HIV-negative individuals may be achievable with conventional means, even in settings with a high burden of HIV-associated TB...
  21. ncbi request reprint Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners
    Elizabeth L Corbett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom
    Am J Respir Crit Care Med 170:673-9. 2004
    ..The difference in mean duration of smear positivity was particularly marked and, if generalizable, will have major implications for TB control prospects in high HIV prevalence areas...
  22. ncbi request reprint Does tuberculosis increase HIV load?
    John H Day
    London School of Hygiene and Tropical Medicine, London, United Kingdom
    J Infect Dis 190:1677-84. 2004
    ..The effect that tuberculosis (TB) has on human immunodeficiency virus (HIV) disease progression is not clearly understood...
  23. ncbi request reprint Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study
    Alison D Grant
    Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, England
    JAMA 293:2719-25. 2005
    ....
  24. ncbi request reprint Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy
    Dale A Babb
    Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Psychol Health Med 12:314-20. 2007
    ..Concomitant use with ART has the potential for drug interactions and should be discussed routinely in ART counselling. Further work is warranted to investigate whether commonly used traditional medicines interact with ART in vivo...
  25. ncbi request reprint HIV infection and chronic chest disease as risk factors for bacterial pneumonia: a case-control study
    Salome Charalambous
    Aurum Health Research, Welkom, South Africa
    AIDS 17:1531-7. 2003
    ..To investigate risk factors for severe acute pneumonia in South African gold miners...